Last reviewed · How we verify
NCT05071521
The Effectiveness of an Eating Disorders Prevention Program for Young Women in Saudi Arabia
NA trial testing The Body Project: A Dissonance-Based Eating Disorder Prevention Intervention in Eating Disorder Symptom and Body Image Dissatisfaction in 92 participants. Completed in 7 March 2021.
7 March 2021
Quick facts
| Lead sponsor | University of Sheffield |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 92 |
| Start date | 1 October 2020 |
| Primary completion | 7 March 2021 |
| Estimated completion | 7 March 2021 |
| Sites | 1 location across Saudi Arabia |
Drugs / interventions tested
- The Body Project: A Dissonance-Based Eating Disorder Prevention Intervention
Conditions studied
- Eating Disorder Symptom and Body Image Dissatisfaction — all drugs for Eating Disorder Symptom and Body Image Dissatisfaction →
Sponsor
University of Sheffield
Who can join
Adults 16 to 25, female only, with Eating Disorder Symptom and Body Image Dissatisfaction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The trial is a randomized control trial about the effective of an eating disorders prevention programmer for young Saudi women. The prevention program is title The Body Project. Participants will be Saudi undergraduates from Princess Nourah Bint Abdulrahman University. Sample size is 64 participants. They will be divided randomly to two groups, each group has 32 participants. The first group is the intervention group where the prevention program will be provided. The second group will be the control group where healthy eating education material will be provided. The outcomes will be measured with adapted tools to local culture at three points (pre, post and 3 month follow-up).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05071521
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Sheffield trials
Trials by the same sponsor.
- NCT07049042 — Hypogonadotrophic Hypogonadism in Genetic Neurodevelopmental Conditions · recruiting
- NCT07132879 — Telehealth in MND-Research (TIM-R): A Research Database for MND · recruiting
- NCT06628427 — Unlock the Secrets of Ageing Brains Through P300 Brain-computer Interface Games · not yet recruiting
- NCT06476483 — Feasibility and Acceptability of Implementing DIALOG+ in a Psychiatric Rehabilitation Unit · NA · completed
- NCT06508840 — The Clear Conversations Project · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05071521 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Sheffield
- Last refreshed: 8 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05071521.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing